MONICA STASSI-FRITZ: Open Payments
NPI 1982185328 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 16 payments from 10 companies in 2025. Trend: 2023 $329 · 2024 $172 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Astellas Pharma US Inc | 3 | $42 |
| 180 Medical, Inc. | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $34 |
| ACCORD HEALTHCARE, INC. | 1 | $27 |
| Caris MPI, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| UROGEN PHARMA, INC. | 1 | $17 |
| COLOPLAST CORP | 1 | $17 |
| Teleflex LLC | 1 | $15 |
Products named: Xtandi, Nubeqa, ERLEADA, Camcevi, MI CANCER SEEK, Luja Coude, BARRIGEL.
Industry payments across MN — which companies pay providers there.
